跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ciprosan - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Ciprosan
Approved
STANDARD
Ciprosan
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
62130ec13abf60e2
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
62130ec13abf60e2
Drug Approval Philippines Name
Ciprosan
Product Name
Ciprosan
Registration Number
DRP-3801
Brand Name
Ciprosan
Generic Name
Ciprofloxacin (As Hydrochloride)
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
27 July 2020
Expiry Date
18 November 2025
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
62130ec13abf60e2
Type
Standard
Back to Philippines FDA Approvals